ClinicalTrialsFinder

T Lymphoblastic Leukemia/Lymphoma Clinical Trials in Harbin, Heilongjiang

1 recruitingHarbin, Heilongjiang, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

PA3-17 Injection in Adult Patients With CD7-positive Relapsed/Refractory T-lymphoblastic Leukemia/Lymphoma

CD7-positive Relapsed/Refractory T Lymphoblastic Leukemia/Lymphoma
PersonGen BioTherapeutics (Suzhou) Co., Ltd.100 enrolled15 locationsNCT07188610